Xiao-I Corp Faces Nasdaq MVPHS Deficiency, Renewing Delisting Threat
AIXI is trading near its 52-week low of $0.96 (9.4% above the low) on elevated volume (5.6× avg).
Summary
Xiao-I Corp received a Nasdaq deficiency notice for failing to maintain a $15 million minimum market value of publicly held shares, adding a new delisting threat just two months after resolving a bid-price compliance issue.
Key Events · Legal and Risk Events · AIXI
-
Nasdaq MVPHS Deficiency Notice
On August 6, 2026, Xiao-I Corp received notice that its market value of publicly held shares (MVPHS) fell below the $15 million minimum for 30 consecutive business days through August 4, 2026.
-
180-Day Compliance Period
The company has until February 1, 2027, to regain compliance by maintaining an MVPHS of at least $15 million for 10 consecutive business days.
-
Delisting Risk
If compliance is not regained, Nasdaq will issue a delisting notice, which the company may appeal. Failure would move trading to the OTC market, severely limiting liquidity and capital access.
-
Precarious Financial Position
With a market cap of only $975.8K and a recent going-concern warning, the company faces extreme difficulty in achieving a $15 million public float without a dramatic share price increase or dilutive financing.
Analysis · AIXI · Technology
A fresh listing deficiency has emerged for Xiao-I Corp after Nasdaq notified the company that its market value of publicly held shares (MVPHS) fell below the required $15 million for 30 consecutive days. This is separate from the bid-price issue resolved in June. The company now has 180 days to regain compliance, but with a market cap under $1 million and a recent history of going-concern warnings and deeply dilutive financings, the path to a $15 million public float is extremely narrow. A delisting would likely force the stock to the OTC, further impairing liquidity and access to capital.
At the time of this filing, AIXI was trading at $1.05 on NASDAQ in the Technology sector, with a market capitalization of approximately $975.8K. The 52-week trading range was $0.96 to $54.20. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.